Fangyu Peng, M.D., Ph.D., is a physician-scientist who practices clinical nuclear medicine, with research interest in PET translational imaging and cancer therapy.

Dr. Peng is conducting translational research of inherited and acquired copper metabolism disorders in Wilson's disease, Alzheimer's disease, and traumatic brain injury.

Dr. Peng is studying copper metabolism as a theranostic target for molecular imaging and cancer therapy.


Medical School
Jiangxi Medical College (1982)
Graduate School
University of South Florida (1994), Medical Microbiology & Immunology
Ball Memorial Hospital (1996), Hematopathology
SUNY Upstate Medical University (1998), Pathology
University of Connecticut Health Center (2000), Nuclear Medicine
Hartford Hospital (2002), Anatomic Pathology
Warren Grant Magnuson Clinical Center - NIH (2003), Nuclear Medicine

Specialty Areas

Research Interest

  • Metabolic imaging of copper metabolism imbalance in Wilson's disease, Alzheimer's disease, and traumatic brain injury
  • Targeting copper metabolism for molecular cancer imaging and therapy


Featured Publications LegendFeatured Publications

(64)CuCl2 PET/CT imaging of mouse muscular injury induced by electroporation.
Xie F, Cai H, Peng F Am J Nucl Med Mol Imaging 2017 7 1 33-39
Ectopic Thyroid Tissue in the Mediastinum Characterized by Histology and Functional Imaging with I-123 SPECT/CT.
Hummel J, Wachsmann J, Carrick K, Oz OK, Mathews D, Peng F Case Rep Radiol 2017 2017 9084207
Asymmetric radiotracer activity of enlarged cerebral spinal fluid space on radionuclide cisternography with SPET/CT.
Bulman JC, Wachsmann J, Peng F Hell J Nucl Med 2016 Nov
Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT.
Wachsmann JW, Ganti R, Peng F Acad Radiol 2016 Nov
Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma.
Wachsmann J, Peng F World J. Gastroenterol. 2016 Jan 22 1 221-31
Detection of Widespread Metastasis in a Case of Aggressive Carcinoma Showing Thymuslike Differentiation (CASTLE Disease) Using 18F-FDG PET/CT.
Iyamu I, Wachsmann J, Truelson J, Mathews D, Peng F Clin Nucl Med 2015 Apr
Reduced 64Cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate Cancer.
Cai H, Wu JS, Muzik O, Hsieh JT, Lee RJ, Peng F J. Nucl. Med. 2014 Mar

Professional Associations/Affiliations

  • American Society of Neurochemistry (2017)
  • International Society to Advance Alzheimer¬ís Research and Treatment (2016)
  • International Society for Neurochemistry (2015)
  • American College of Nuclear Medicine (2014)
  • Society of Nuclear Medicine and Molecular Imaging (1998)